Federal Reserve’s Rate Cut: Don’t Expect Immediate Reliefby Mark Eisenberg 19.04.2024Federal Reserve Chair Jerome Powell won't cut rates simply because of public pressure. Even though rates remain high, historical context ...
23andMe CEO Considers Taking DNA Tester Privateby Mark Eisenberg 19.04.2024The personalized DNA revolution falls short as a company's stock plummets by 90%. Valued at $3.5 billion, it seeks potential ...
Bitcoin Price Forecast for April 19, 2024by John Darbie 19.04.2024In the dynamic world of cryptocurrency, this financial analysis explores Bitcoin's potential price movements in the next 24 hours based ...
Minerva Surgical, Inc.: Financial Report Analysisby Terry Bingman 18.04.2024Minerva Surgical, Inc., a healthcare company specializing in women's uterine healthcare solutions, faces financial challenges with negative margins and declining ...
Microsoft Earnings Preview: Strong Growth Expectedby Lilu Anderson 18.04.2024Microsoft expects a growth rate of 11% YoY, excluding Activision, due to strong Azure and M365 performance. Achieving a 30% ...
Breakthrough Vaccine: One Shot Protects Against All Virus Strainsby Lilu Anderson 18.04.2024Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
Crypto Analyst Predicts Future Prices for Dogecoin, XRP, and Bitcoinby John Darbie 18.04.2024Crypto analyst Ash Crypto predicts a $1 price target for Dogecoin by 2025, while XRP could reach between $3 and ...
Alignment Healthcare, Inc.: Financial Report Reveals Industry Challengesby Mark Eisenberg 18.04.2024Alignment Healthcare, Inc. (ALHC) is a Medicare advantage company with revenue growth of 28.6%. Stock price at $5.02, analysts recommend ...
Cathie Wood Betters Portfolio with Rising Energy Stocksby Mark Eisenberg 09.04.2024Energy and utilities thrived in the stock market today, while Cathie Wood's purchase of Tesla led to a drop in ...
Teladoc Health Vs. Novavax: Stock Picks and Avoidanceby Mark Eisenberg 09.04.2024Teladoc Health's revenue grew by 8% to $2.6 billion in 2023, with a gross margin of 70.8%. On the other ...